arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Cadre Holdings, Inc.

CDRE
$32.83 ▼ -2.17 (-6.20%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
7 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
64
Health
Fair
Bullish
auto_awesome

Analytical Summary

Cadre Holdings, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $1.3B
Dividend Yield 0.29%
Revenue Growth 7.5%
Op. Margin 11.0%
ROIC 7.8%
FCF / Share $1.39
Trailing P/E 30.4x
Price / Book 4.4x
FCF Yield 4.2%
Debt / Equity 0.92
info Valuation on last close. End-of-day price, Aug 7, 2026.

7-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$610.31M
↑ +7.5%
Net Income Profit after all expenses
$44.14M
↑ +22.2%
Operating Margin Operating profit as % of sales
11.0%
↓ -6.2% 59th
FCF / Share Free cash flow per share
$1.39
↑ +112.8%
Long-Term Debt Long-term obligations
$290.99M
↑ +37.4%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
58
Returns
78
Financial Health
50
Cash Quality
75

Dividend History

Dividend / share · sourced from SEC filings
$0.10 Latest / share
+8.6% YoY
+5.9% 4-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters